Testosterone Level Monitoring During Replacement Therapy
Patients on testosterone replacement therapy should have testosterone levels checked 2-3 months after treatment initiation, without fasting, with the timing of blood draw dependent on the formulation used. 1
Timing of Monitoring
Testosterone level monitoring should follow these guidelines:
- Initial follow-up: Check testosterone levels 2-3 months after starting treatment 1
- After dose adjustments: Recheck levels 2-3 months after any dose changes 1
- Maintenance monitoring: Once stable, check every 6-12 months 1
Fasting Requirements
- No fasting required: There is no recommendation in current guidelines that patients need to fast for testosterone level checks 2, 1
- For oral testosterone undecanoate: Blood should be drawn with food consumption since the medication is absorbed with dietary fat 3
- For injectable testosterone: Blood should be drawn at the appropriate time based on formulation:
Target Testosterone Levels
The American Urological Association (AUA) recommends:
- Target testosterone levels in the mid-normal range (450-600 ng/dL) 2
- Adjust dosing to achieve total testosterone levels in the middle tertile of the normal reference range 2
Formulation-Specific Monitoring Considerations
Different testosterone formulations require specific monitoring approaches:
Transdermal Gels/Patches
- Check levels 2-3 months after initiation 1
- For more precise monitoring, consider checking at both peak (+2 hours after application) and trough (+23 hours) 5
- Research shows significant differences between peak and trough levels with transdermal formulations 5
Injectable Testosterone
- For short-acting formulations (enanthate/cypionate): Check levels midway between injections 1
- For long-acting testosterone undecanoate: One injection every 3 months maintains serum testosterone within normal range 4
Testosterone Pellets
Additional Monitoring Parameters
Beyond testosterone levels, monitor:
- Hematocrit/hemoglobin (risk of erythrocytosis)
- Blood pressure (testosterone can increase BP) 3
- PSA and digital rectal examination for prostate health 1
- Bone density in hypogonadal men at risk for osteoporosis
Common Pitfalls to Avoid
- Incorrect timing of blood draws: Drawing blood at inappropriate times relative to dose administration can lead to misleading results
- Failure to monitor for adverse effects: Monitor for erythrocytosis, hypertension, and prostate changes
- Inadequate dose adjustments: Follow the recommended dose adjustment table based on pre-dose morning testosterone levels 1
- Overlooking cardiovascular risk: Monitor blood pressure regularly as testosterone can increase BP and cardiovascular risk 3
Algorithm for Monitoring
- Baseline: Confirm hypogonadism with two morning testosterone measurements
- Initiate appropriate testosterone formulation
- Check testosterone levels at 2-3 months
- Adjust dose if needed based on levels and symptoms
- Recheck levels 2-3 months after any dose adjustment
- Once stable, monitor every 6-12 months
- Monitor for adverse effects at each visit